![Gidi Benyamini](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Gidi Benyamini
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Notal Vision Ltd.
![]() Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Director de Operaciones | 04/03/2013 | - |
Corporate Officer/Principal | - | 04/03/2013 |
Historial de carrera de Gidi Benyamini
Antiguos cargos conocidos de Gidi Benyamini.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
LaserComm Ltd. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
Israel | 3 |
Operativa
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Sectorial
Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Notal Vision Ltd.
![]() Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Health Services |
LaserComm Ltd. |
- Bolsa de valores
- Insiders
- Gidi Benyamini
- Experiencia